Novo Nordisk (Denmark) (Q332826): Difference between revisions

From geokb

Latest revision as of 18:37, 10 September 2024

company organization in Copenhagen, Denmark

Language	Label	Description	Also known as
English	Novo Nordisk (Denmark)	company organization in Copenhagen, Denmark

Statements

0 references

addresses subject

Management of Diabetes Mellitus and Cardiovascular Risk

1,694

1 reference

https://openalex.org/I189090001

Management of Diabetes Mellitus and Hypoglycemia

1,360

1 reference

https://openalex.org/I189090001

Pancreatic Islet Dysfunction and Regeneration

924

1 reference

https://openalex.org/I189090001

Role of AMP-Activated Protein Kinase in Cellular Metabolism

851

1 reference

https://openalex.org/I189090001

Management and Treatment of Hemophilia

678

1 reference

https://openalex.org/I189090001

Hadron Physics and QCD

477

1 reference

https://openalex.org/I189090001

Thrombosis and Coagulation Disorders

475

1 reference

https://openalex.org/I189090001

Genetics and Pathogenesis of Type 1 Diabetes

435

1 reference

https://openalex.org/I189090001

Particle Physics and High-Energy Collider Experiments

407

1 reference

https://openalex.org/I189090001

Holographic Derivation of Field Theories and Gravity

328

1 reference

https://openalex.org/I189090001

Structure and Function of G Protein-Coupled Receptors

319

1 reference

https://openalex.org/I189090001

Insulin-like Growth Factors in Health and Disease

289

1 reference

https://openalex.org/I189090001

Theoretical and Experimental Nuclear Structure

279

1 reference

https://openalex.org/I189090001

Search for Quark-Gluon Plasma in Heavy-Ion Collisions

261

1 reference

https://openalex.org/I189090001

Pharmacological Management of Obesity

253

1 reference

https://openalex.org/I189090001

Platelet Disorders and Thrombosis Mechanisms

250

1 reference

https://openalex.org/I189090001

Cosmological Parameters and Dark Energy

248

1 reference

https://openalex.org/I189090001

Protein Aggregation and Biopharmaceutical Stability

235

1 reference

https://openalex.org/I189090001

Brown Adipose Tissue Function and Physiology

211

1 reference

https://openalex.org/I189090001

Therapeutic Antibodies: Development, Engineering, and Applications

208

1 reference

https://openalex.org/I189090001

Role of Neuropeptides in Physiology and Disease

207

1 reference

https://openalex.org/I189090001

High-Temperature Superconductivity

196

1 reference

https://openalex.org/I189090001

Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders

194

1 reference

https://openalex.org/I189090001

Neuroendocrine Regulation of Appetite and Body Weight

192

1 reference

https://openalex.org/I189090001

Quantum Effects in Helium Nanodroplets and Solids

191

1 reference

https://openalex.org/I189090001

coordinate location

55°45'17"N, 12°27'12"E

1 reference

https://openalex.org/I189090001

Kingdom of Denmark

1 reference

https://openalex.org/I189090001

official website

http://www.novonordisk.com/

1 reference

https://openalex.org/I189090001

0 references

Research Organization Registry ID

0 references

is subsidiary of

Novo Holdings (Denmark)

1 reference

https://openalex.org/I189090001

http://www.wikidata.org/entity/Q818846

1 reference

https://openalex.org/I189090001

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q332826&oldid=1273424"